PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 112 filers reported holding PROVENTION BIO INC in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $32,291 | +621.7% | 1,339,905 | +216.5% | 0.02% | +800.0% |
| Q4 2022 | $4,474 | -97.4% | 423,295 | +895.1% | 0.00% | – |
| Q2 2022 | $170,000 | -94.5% | 42,540 | -92.2% | 0.00% | -100.0% |
| Q4 2021 | $3,070,000 | -38.8% | 546,202 | -30.3% | 0.00% | -33.3% |
| Q3 2021 | $5,015,000 | +5.5% | 783,522 | +39.0% | 0.00% | 0.0% |
| Q2 2021 | $4,752,000 | +34.8% | 563,688 | +67.8% | 0.00% | 0.0% |
| Q1 2021 | $3,526,000 | +39.9% | 335,961 | +125.8% | 0.00% | +50.0% |
| Q4 2020 | $2,521,000 | +25.7% | 148,808 | -4.8% | 0.00% | 0.0% |
| Q3 2020 | $2,006,000 | -77.1% | 156,320 | -74.8% | 0.00% | -83.3% |
| Q2 2020 | $8,763,000 | +64.3% | 621,070 | +7.1% | 0.01% | 0.0% |
| Q1 2020 | $5,335,000 | +859.5% | 579,866 | +1454.1% | 0.01% | +1100.0% |
| Q4 2019 | $556,000 | +283.4% | 37,313 | +75.0% | 0.00% | – |
| Q3 2019 | $145,000 | – | 21,324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |